| 产品名 | |||
| Givinostat (ITF2357) | HDAC | 类风湿性关节炎,骨髓增殖性疾病,白血病 | Phase 3 |
| Cilengitide | Integrin | 星形细胞瘤 | Phase 3 |
| Rocilinostat (ACY-1215) | HDAC | 骨髓瘤,淋巴瘤 | Phase 1/2 |
| Tivantinib (ARQ 197) | c-Met | 肝细胞癌 | Phase 3 |
| SNS-032 (BMS-387032) | CDK | 淋巴瘤,骨髓瘤 | Phase 1 |
| AZD5438 | CDK | 恶性肿瘤 | Phase 1 |
| AT7519 HCl | CDK | 白血病,淋巴瘤,骨髓瘤 | Phase 2 |
| Tipifarnib | Transferase | 白血病 | Phase 3 |
| PRT062607 HCl | Syk | 类风湿性关节炎,红斑狼疮 | Phase 1 |
| Erismodegib (NVP-LDE225, LDE225) | Hedgehog/Smoothened | 皮肤癌 | Phase 2 |
| GSK461364 | PLK | 淋巴瘤 | Phase 1 |
| Elesclomol (STA-4783) | HSP (e.g. HSP90) | 卵巢癌,白血病,肺癌,前列腺癌 | Phase 3 |
| LY2603618 | Chk | 肺癌,胰腺癌 | Phase 2 |
| Vadimezan (ASA404, DMXAA) | VDA | 肺癌 | Phase 3 |
| EPZ5676 | Histone Methyltransferase | 白血病 | Phase 1 |
| Quisinostat (JNJ-26481585) | HDAC | 淋巴瘤 | Phase 2 |
| MLN8054 | Aurora Kinase | 恶性肿瘤 | Phase 1 |
| Baricitinib (LY3009104, INCB028050) | JAK | 类风湿性关节炎 | Phase 3 |
| Zosuquidar (LY335979) 3HCl | P-gp | 白血病 | Phase 1/2 |
| ARN-509 | Androgen Receptor | 前列腺癌 | Phase 2 |
| Sapitinib (AZD8931) | HER2 | 肺癌,乳腺癌 | Phase 2 |
| KX2-391 | Src | 乳腺癌,前列腺癌,胃癌,白血病 | Phase 2 |
| VX-702 | p38 MAPK | 类风湿性关节炎 | Phase 2 |
